<dl id="4qnlw"><progress id="4qnlw"><ruby id="4qnlw"></ruby></progress></dl>
  • <li id="4qnlw"></li>

  • <button id="4qnlw"></button>
    <th id="4qnlw"><legend id="4qnlw"></legend></th>
  • <button id="4qnlw"></button>
    <th id="4qnlw"><legend id="4qnlw"></legend></th>


    Partnering plays a strategic role in executing our R&D strategy, evolving our portfolio and growth. Our goal in partnering is to discover, develop and deliver transformational medicines to patients by bringing innovative science, research and technology together with our capabilities and expertise.

    Partnering to Speed: Transformational Medicines to Patients

    Partnering to Speed:?Transformational
    Medicines to Patients

    Combining passion, science and experience to deliver innovation together.

    Why Partner With Us

    With a long history of successful scientific and commercial collaborations that exhibit speed, collaboration, innovation, and strong partner relationships, research and development (R&D) is at the center of our strategy. With 41 compounds in development, a network of research facilities around the globe, and an annual R&D investment of $4.8 billion*,? we’ve been recognized as one of the premier R&D organizations in the industry.

    *This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items.?

    What We're Focused On

    We are focused on building a differentiated portfolio of transformational medicines for patients with serious and life-threatening diseases. There are a number of areas of focus across disease areas, drug platforms and technologies that we are interested in bringing together with our expertise to help speed medicines to patients.

    Existing Partnerships

    In order to develop innovative medicines, we collaborate with top tier organizations and research institutes around the world.

    Common Cold

    Working to #HackCancer

    Bristol-Myers Squibb Joins Parker Institute and Cancer Research Institute to Accelerate I-O Research

    Contact us about partnering

    Start the partnership process. Please send NON-CONFIDENTIAL information about your opportunity to one of the individuals below based on your area of interest:

    Oncology: BD-Onc@bms.com
    Hematology & Cell Therapy: BD-HemaCT@bms.com
    Neuroscience & CV: BD-NeuroCV@bms.com
    Fibrosis & Immunology: BD-FibImm@bms.com
    PDx and Biomarker: BD-PDxBiomarkers@bms.com
    Research and Enabling Transactions:?BD-RET@bms.com
    Digital Health Initiatives: BD-DHI@bms.com
    Corporate Development: BD-CorpDev@bms.com